Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”I’m delighted to announce the newly published English edition of our book: ‘Gene Therapy Concepts in the Treatment of Haemophilia’.
After decades of research, gene therapies for Haemophilia A and B are now a reality – with the potential to sustainably improve patients’ quality of life and speak of phenotypic cure for the first time.
The book provides up-to-date information on:
- Basics of Haemophilia
From pathophysiology to therapy with clotting factors and subcutaneous agents.
- Gene Therapy Approaches and Current Study Results
AAV, Lentivirus, Gene Editing, and other therapeutic concepts.
- Patient Selection and Individual Therapy
Criteria for selecting suitable patients.
- Immunology
Immune responses to AAV-mediated gene therapy, immunohematology, challenges with antibodies and immune reactions.
- Laboratory and Diagnostics
Monitoring clotting factor levels, lab diagnostics, quality control, and new lab methods.
- Liver-Related Issues
Impacts of gene therapy on the liver and its function.
- Interdisciplinary Collaboration
Necessity and benefits of the “Hub and Spoke” model for care.
- Future Perspectives and Innovation
Opportunities, challenges, and outlook on personalized medicine and innovative therapies.
- Shared Decision Making
Active involvement of patients and treaters in therapy decisions, especially for gene therapy selection and education.
A clear recommendation for everyone interested in innovative therapies, translating research into the clinic, and the future of personalized medicine.”
Stay updated with Hemostasis Today.
-
Apr 29, 2026, 07:12Matteo Foschi: Is There a Benefit to Switching DOACs After Breakthrough Stroke?
-
Apr 29, 2026, 07:02Enrico Ferro: Stroke Risk in PFA vs Radiofrequency Ablation
-
Apr 29, 2026, 06:03Proud to Recognize 6 Early Career Investigators as the Recipients of the 2026 JTH Editors’ Awards – JTH
-
Apr 29, 2026, 05:55On Hemophilia Care Advances, Collaboration and Access in India at IHC X 2026 – Hemophilia Federation India
-
Apr 29, 2026, 05:46Rajendra Tapadia: Strengthening Last-Mile Hemophilia Care Through Structured Community Outreach
-
Apr 29, 2026, 05:37Masoabi Sefojane: Whose Realities Shape Global Priorities in Hemophilia Care?
-
Apr 29, 2026, 05:24Filippo Cademartiri: Mandatory Reading for Anyone Who Mistakes Expertise for Certainty
-
Apr 29, 2026, 02:52Fengqian Chen: Another Reality Check for the Factor XI Inhibitor Race – Novartis’ Abelacimab Setback
-
Apr 29, 2026, 02:18Arnaud Baldivia: Peri-Procedural Stroke – An Underestimated Emergency in the Operating Room and in the ICU